🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In 2022, Mayo Clinic physicians and scientists interrogated the genome, exome, proteome, epigenome, exposome, transcriptome and more with remarkable depth to shed new light on the hidden biological signatures of cancer. mayocl.in/3VFiwxz

Every day has the potential of discovery even for the people and things we think we know. Over the past 50 years, “Toblerone” has been my favorite chocolate. Yet, I never noticed “the bear on the logo”. Be observant to discover.

To study bile is not easy. To study bile of a rare disease like patients with primary sclerosing cholangitis for detecting environmental chemicals using high resolution mass spec is almost a Herculean effort. Kudos to the team pubmed.ncbi.nlm.nih.gov/36687160/

Democratizing genomic testing for diagnosed rare disease improves the care of 42% of patients. The power of enabling the specialist to provide genomic-based clinical care …nslational-medicine.biomedcentral.com/articles/10.11…

You can wait for the future, predict the future, or create the future -knl070723

Mayo Clinic researchers have discovered a link between an abundance of specific gut bacteria and the triggering of an immune response against a person's tissue. They also found this happens even before the clinical symptoms of rheumatoid arthritis appear. mayocl.in/45V6VQT

We live in a dynamic environment that changes faster than our genes. We must study exposures in a systematic, scalable manner to understand how exposures could contribute to disease or protect from disease via ⁦The New York Times⁩ ⁦Mayo Clinic Center for Individualized Medicine⁩ nytimes.com/2024/01/11/wel…

The Functional Omics Symposium is a free event on May 15 & 16. Speakers from Medical College of Wisconsin University of Minnesota University of Illinois CMT4B3 Research Foundation & Mayo Clinic discuss the evolution of functional omics, cutting-edge clinical trials & collaboration, and more. Register: bit.ly/4b4dCTb

An elaborate study of epigenetic markers in primary sclerosing cholangitis and primary biliary cholangitis. Accelerated biological aging and hypomethylation are characteristic of both disease although methylated associated genes differ. journals.lww.com/hepcomm/fullte…

A 40,000+ Participants Decentralized Exome Sequencing Study Identifies Almost 40% More Carriers of Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations. Kudos to Tapestry team for your dedication. ascopubs.org/doi/10.1200/PO…

New ARPA-H project! IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization. Chirag Patel xin hu Randolph Singh Mayo Clinic Mayo Clinic Center for Individualized Medicine Emory Clinical Biomarkers Lab Douglas Walker, PhD Columbia University Harvard Medical School Columbia Vagelos College of Physicians & Surgeons publichealth.columbia.edu/news/research-…

Diseases caused by toxic chemicals and plastics can be prevented with scientific discovery, willingness of scientists to translate science into policy, and policy makers acting on the science. Dr. Philip Landrigan Boston College #CIMCON2024 #keynote.

Alison Motsinger-Reif, PhD, Niel, is taking #CIMCON2024 attendees through the Personalized Environment and Genes Study, including how they are bringing multiple studies together to discover how the environment and genes affect our health.

Happening now at #CIMCON2024: Population omics in practice panel w/ Melissa B Davis, PhD Weill Cornell Medicine Surgery @NIEHS Iftikhar J. Kullo Mayo Clinic CV

Were you spotted? #CIMCON2024 attendees at the interactive networking lunch on day 1.

"Label-free optical imaging techniques have the potential to change the paradigm for when, where & how tissue is assessed microscopically," says Dr. Stephen Boppart, M.D., Ph.D. University of Illinois & Biophotonics Imaging Laboratory at #CIMCON2024.

AI can help look at current processes and help improve efficiency and innovation in laboratory genetics and genomics, per Cherisse Marcou, PhD @MayoClinicLabs, speaking at #CIMCON2024.

Exciting news! Mayo Clinic Center for Individualized Medicine has a key role in groundbreaking research funded by ARPA-H to explore how environmental exposures interact with genetics to affect treatment responses. Imagine a future where meds are tailored to your genes and environment! mayocl.in/3XDgous

Lots of great Q&A's during digital omics panel discussion at #CIMCON2024 w/ University of Illinois Biophotonics Imaging Laboratory Brad Erickson MayoAILab @MayoClinicLabs.